The National Clinical Trials and Research Center (NCTRC) at the National Taiwan University Hospital has tapped Icon, a CRO founded in Dublin in 1990, to help it enhance the set-up and management of clinical studies in Taiwan.

Per the agreement, NCTRC and Icon will work together on study start-up, site feasibility, key site and investigator selection, and patient recruitment. Both organizations will also be working together to enhance clinical research standards in Taiwan.

“Our customers are increasingly looking to include Taiwan in their clinical programs and are expecting fast timelines for study start-up and patient recruitment,” said Wei Ming Goh, Icon’s vp, Asia-Pacific, in a statement. “By combining the proven expertise of Icon and NCTRC in the region, we can further accelerate study timelines which will benefit our customers and also enhance the Taiwanese clinical trials industry.”

Previous articleGEN Publisher & CEO Honored for Stem Cell Education
Next articleMath Casts New Light on Long-Studied Biological Process